Watchlist Price Alert

Keros Therapeutics Inc. (KROS)

NASDAQ: KROS · Real-Time Price · USD

13.61

-0.05 (-0.37%)

At close: Jun 17, 2025, 1:49 PM

Keros Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	559.93M	331.15M	279.05M	230.04M	265.88M	7.02M	23.26M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	1.21M	1.33M	1.33M	115K	115K	501K
Other Long-Term Assets	3.5M	2.05M	2.12M	82K	n/a	n/a	n/a
Receivables	4.46M	1.09M	841K	18M	216K	922K	n/a
Inventory	n/a	n/a	-841K	3.06M	1.47M	759K	n/a
Other Current Assets	1.48M	1M	180K	340K	160K	819K	84K
Total Current Assets	588.89M	347.29M	285.77M	251.44M	267.73M	8.93M	25.53M
Property-Plant & Equipment	23.49M	19.47M	17.57M	2.4M	1.6M	1.91M	1.38M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	26.99M	22.73M	21.01M	3.81M	1.72M	2.03M	1.88M
Total Assets	615.89M	370.02M	306.78M	255.25M	269.44M	10.96M	27.41M
Account Payables	4.6M	5.45M	3.34M	3.65M	2.15M	2.09M	501K
Deferred Revenue	n/a	n/a	n/a	7.13M	4.39M	1.92M	10M
Short-Term Debt	1.98M	n/a	455K	862K	423K	n/a	n/a
Other Current Liabilities	10.55M	10.38M	7.49M	3.99M	2.49M	1.23M	477K
Total Current Liabilities	27.45M	24.37M	16.55M	11.85M	7.18M	4.49M	11.47M
Long-Term Debt	n/a	n/a	12.81M	231K	476K	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	-12.81M	-231K	-414K	5.08M	2.56M
Total Long-Term Liabilities	16.88M	13.44M	12.81M	231K	538K	1.02M	3.19M
Total Liabilities	44.33M	37.81M	29.36M	12.08M	7.72M	5.5M	14.65M
Total Debt	18.86M	14.44M	13.27M	1.09M	899K	1.27M	788K
Common Stock	4K	3K	2K	2K	2K	2K	1K
Retained Earnings	-568.78M	-381.43M	-228.43M	-123.75M	-65.01M	-19.65M	-7.31M
Comprehensive Income	n/a	0.00	-0.00	-0.00	-269.44M	-19.94M	-246K
Shareholders Equity	571.55M	332.21M	277.42M	243.17M	261.72M	5.45M	12.76M
Total Investments	n/a	1.21M	1.33M	1.33M	115K	115K	501K